İsmail Çeli̇k

3.7k total citations · 1 hit paper
190 papers, 2.6k citations indexed

About

İsmail Çeli̇k is a scholar working on Organic Chemistry, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, İsmail Çeli̇k has authored 190 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Organic Chemistry, 60 papers in Molecular Biology and 40 papers in Computational Theory and Mathematics. Recurrent topics in İsmail Çeli̇k's work include Synthesis and biological activity (72 papers), Computational Drug Discovery Methods (40 papers) and Crystal structures of chemical compounds (30 papers). İsmail Çeli̇k is often cited by papers focused on Synthesis and biological activity (72 papers), Computational Drug Discovery Methods (40 papers) and Crystal structures of chemical compounds (30 papers). İsmail Çeli̇k collaborates with scholars based in Türkiye, India and Saudi Arabia. İsmail Çeli̇k's co-authors include Renata Kontek, Mateusz Kciuk, Żaneta Kałuzińska‐Kołat, Damian Kołat, Somdutt Mujwar, Adrianna Gielecińska, Trina Ekawati Tallei, Ulviye Acar Çevik, Rohitash Yadav and Yusuf Özkay and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

İsmail Çeli̇k

181 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity

2023 385 citations İsmail Çeli̇k et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
İsmail Çeli̇k Türkiye	27	1.0k	843	443	270	235	190	2.6k
Sankaranarayanan Murugesan India	32	1.7k 1.6×	1.1k 1.3×	449 1.0×	332 1.2×	334 1.4×	204	3.4k
Ashfaq Ur Rehman Pakistan	31	1.1k 1.1×	1.3k 1.5×	528 1.2×	239 0.9×	187 0.8×	122	2.9k
Dharmendra Kumar Yadav India	33	760 0.8×	1.5k 1.8×	574 1.3×	421 1.6×	342 1.5×	196	3.7k
Tuğba Taşkın‐Tok Türkiye	25	1.0k 1.0×	768 0.9×	450 1.0×	320 1.2×	269 1.1×	154	2.1k
Faizan Abul Qais India	29	496 0.5×	1.1k 1.3×	314 0.7×	210 0.8×	317 1.3×	93	2.5k
Afzal Hussain Saudi Arabia	34	487 0.5×	1.5k 1.8×	675 1.5×	308 1.1×	324 1.4×	137	3.2k
Parvesh Singh South Africa	28	2.4k 2.4×	1.2k 1.5×	261 0.6×	303 1.1×	257 1.1×	163	3.8k
Sang‐Hun Jung South Korea	31	1.4k 1.3×	1.3k 1.6×	419 0.9×	380 1.4×	184 0.8×	138	4.0k
Mohamed Jawed Ahsan India	29	2.0k 2.0×	870 1.0×	541 1.2×	312 1.2×	130 0.6×	141	3.2k
Jérôme Eberhardt United States	11	740 0.7×	2.0k 2.4×	856 1.9×	371 1.4×	315 1.3×	19	3.9k

Countries citing papers authored by İsmail Çeli̇k

Since Specialization

Citations

This map shows the geographic impact of İsmail Çeli̇k's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İsmail Çeli̇k with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İsmail Çeli̇k more than expected).

Fields of papers citing papers by İsmail Çeli̇k

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by İsmail Çeli̇k. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İsmail Çeli̇k. The network helps show where İsmail Çeli̇k may publish in the future.

Co-authorship network of co-authors of İsmail Çeli̇k

This figure shows the co-authorship network connecting the top 25 collaborators of İsmail Çeli̇k. A scholar is included among the top collaborators of İsmail Çeli̇k based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with İsmail Çeli̇k. İsmail Çeli̇k is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shawky, Eman, et al.. (2025). Insight into potential anti-diabetic metabolites of Sycamore fig (Ficus sycomorus L.) across fruit development using metabolomics and molecular docking. Microchemical Journal. 213. 113597–113597. 1 indexed citations

Tallei, Trina Ekawati, et al.. (2025). Probing the Molecular Mechanisms of Kratom's Antipsychotic Effects through a Multi-modal Computational Approach. Current Pharmaceutical Design. 31(17). 1370–1387.

Özkan, Tülin, et al.. (2024). Synthesis of novel indol-3-acetamido analogues as potent anticancer agents, biological evaluation and molecular modeling studies. Bioorganic Chemistry. 148. 107429–107429. 1 indexed citations

Erkmen, Cem, et al.. (2024). Unraveling the interaction mechanism between orphan drug Nitisinone and bovine serum albumin through spectroscopic and in silico approaches. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 322. 124818–124818. 2 indexed citations

Akkol, Esra Küpeli, et al.. (2024). Sedative and anxiolytic effects of Capparis sicula Duhamel: in vivo and in silico approaches with phytochemical profiling. Frontiers in Pharmacology. 15. 1443173–1443173. 2 indexed citations

Çeli̇k, İsmail, et al.. (2024). Investigating Potential Cancer Therapeutics: Insight into Histone Deacetylases (HDACs) Inhibitions. Pharmaceuticals. 17(4). 444–444. 6 indexed citations

Bender, Onur, İsmail Çeli̇k, Amer Ali Abd El‐Hafeez, et al.. (2024). Discovery and Anticancer Screening of Novel Oxindole-Based Derivative Bearing Pyridyl Group as Potent and Selective Dual FLT3/CDK2 Kinase Inhibitor. Pharmaceuticals. 17(5). 659–659. 4 indexed citations

Çeli̇k, İsmail, et al.. (2023). Computational biology and in vitro studies for anticipating cancer-related molecular targets of sweet wormwood (Artemisia annua). BMC Complementary Medicine and Therapies. 23(1). 312–312. 5 indexed citations

Erkmen, Cem & İsmail Çeli̇k. (2023). Interaction mechanism of a pesticide, Azoxystrobin with bovine serum albumin: Assessments through fluorescence, UV–Vis absorption, electrochemical and molecular docking simulation techniques. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 308. 123719–123719. 9 indexed citations

10.

Çevik, Ulviye Acar, et al.. (2023). New benzimidazole‐oxadiazole derivatives: Synthesis, α‐glucosidase, α‐amylase activity, and molecular modeling studies as potential antidiabetic agents. Archiv der Pharmazie. 356(5). e2200663–e2200663. 10 indexed citations

11.

Tallei, Trina Ekawati, Fatimawali Fatimawali, İsmail Çeli̇k, et al.. (2022). 4’-fluorouridine and its derivatives as potential COVID-19 oral drugs: a review. F1000Research. 11. 410–410. 2 indexed citations

12.

Çeli̇k, İsmail, et al.. (2022). Synthesis, molecular modeling, 3D-QSAR and biological evaluation studies of new benzimidazole derivatives as potential MAO-A and MAO-B inhibitors. Journal of Molecular Structure. 1265. 133444–133444. 4 indexed citations

13.

Çeli̇k, İsmail, et al.. (2022). Novel Benzimidazole-Based Compounds as Antimicrobials: Synthesis, Molecular Docking, Molecular Dynamics and in silico ADME Profile Studies. Acta chimica slovenica. 69(2). 419–429. 12 indexed citations

14.

Çeli̇k, İsmail, et al.. (2022). Design, Synthesis, in Vitro and in Silico Studies of Benzimidazole‐Linked Oxadiazole Derivatives as Anti‐inflammatory Agents. ChemistrySelect. 7(28). 7 indexed citations

15.

Çevik, Ulviye Acar, İsmail Çeli̇k, Ülküye Dudu Gül, et al.. (2022). Synthesis, and docking studies of novel tetrazole-S-alkyl derivatives as antimicrobial agents. Phosphorus, sulfur, and silicon and the related elements. 198(2). 137–144. 2 indexed citations

16.

Çeli̇k, İsmail, et al.. (2022). SARS-CoV-2 Infection may be Prevented with Cytochrome Inhibitors: Cobicistat and Ritonavir. PubMed. 4(3). 185–191.

17.

Çapan, İrfan, et al.. (2022). Synthesis, molecular docking, molecular dynamics and evaluation of Drug-Likeness properties of the fused N -Formyl pyrazoline substituted new dehydroepiandrosterone derivatives. Journal of Biomolecular Structure and Dynamics. 41(6). 2492–2503. 6 indexed citations

18.

Çeli̇k, İsmail, et al.. (2021). Synthesis, in vitro antiprotozoal activity, molecular docking and molecular dynamics studies of some new monocationic guanidinobenzimidazoles. European Journal of Medicinal Chemistry. 221. 113545–113545. 26 indexed citations

19.

Karami, Akbar, Sefren Geiner Tumilaar, Fatimawali Fatimawali, et al.. (2021). In Silico Evaluation of Iranian Medicinal Plant Phytoconstituents as Inhibitors against Main Protease and the Receptor-Binding Domain of SARS-CoV-2. Molecules. 26(18). 5724–5724. 55 indexed citations

20.

Özden, Seçkin, et al.. (2021). Synthesis, NMR, X-ray crystallography and DFT studies of some regioisomers possessing imidazole heterocycles. Journal of Molecular Structure. 1243. 130811–130811. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact